Daily Archives: March 12, 2021
Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019
12 Mar, 2021 | 08:16h | UTCCommentary: Addressing the global burden of hearing loss – The Lancet
Related: WHO Report: 1 in 4 people projected to have hearing problems by 2050
Commentary on Twitter
✨NEW @TheLancet paper by #GBDstudy Hearing Loss Collaborators ➡️?https://t.co/xogUcTn1zC
Over 1.5 billion people are affected by hearing loss. 80% live in low- and middle-income countries. Countries must act now to provide access to ear and hearing care for all. pic.twitter.com/V3ziTORaba
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) March 12, 2021
Study shows increased risk of all-cause mortality in STEMI patients without standard modifiable risk factors
12 Mar, 2021 | 08:13h | UTC
Commentary on Twitter
#Swedish study published in @TheLancet shows patients with myocardial infarction without standard risk factors suffer worse outcomes. Use of guideline-indicated treatments attenuated the risk, underscoring a therapeutic need for this lower-risk group.https://t.co/U49IXNtACK
— The Lancet Reg Health-Europe (@LancetRH_Europe) March 10, 2021
Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis
12 Mar, 2021 | 08:08h | UTC
M-A: Angiographic Patency of Coronary Artery Bypass Conduits
12 Mar, 2021 | 08:10h | UTC
M-A: Early tracheostomy may lower the rates of ventilator-associated pneumonia and ventilator duration in critically ill patients
12 Mar, 2021 | 08:09h | UTCAuthor interview: Early vs Late Tracheotomy for Pneumonia and Ventilator Days
#Tracheostomy placement no more than 7 days after ventilator support may lower the rates of ventilator-associated pneumonia and ventilator duration https://t.co/gVPXoMEorN @Penn_ENT @UTHealthSA
— JAMA Otolaryngology – Head & Neck Surgery (@JAMAOto) March 11, 2021
[Press release – not published yet] Novavax reports 96% efficacy against original strain of COVID-19, 86% efficacy against B.1.1.7 variant, and 55% efficacy against B1.351 variant
12 Mar, 2021 | 08:33h | UTCPress release: Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials
Commentaries: Novavax Reports Its COVID-19 Vaccine is 96% Efficacious, Based on Phase 3 Trial Results – TIME AND Novavax Says Vaccine Is 96% Effective At Preventing Original Covid-19 Virus – Forbes
Commentary on Twitter
Breaking: Novavax announces efficacy results in its vaccine trials.
* 100% protection against severe disease
* 96% effective against symptoms from original virus (higher than Pfizer/BioNTech or Moderna)
* 86% against B-117.
* 55% against B-1.351https://t.co/MexA9SjoCt— Melody Schreiber (@m_scribe) March 11, 2021
ERS Guideline: Management of hospitalized adults with COVID-19
12 Mar, 2021 | 08:36h | UTC
NCCN Best Practices Guidance: Management of COVID-19 Infection in Patients with Cancer
12 Mar, 2021 | 08:31h | UTC
COVID-19 and liver disease: mechanistic and clinical perspectives
12 Mar, 2021 | 08:29h | UTC
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots
12 Mar, 2021 | 08:32h | UTCSee also: More European nations pause AstraZeneca vaccine use as blood clot reports investigated – CNN AND Denmark, Norway and Iceland suspend AstraZeneca COVID shots after blood clot reports – Reuters
Commentary on Twitter
Denmark has temporarily suspended use of the Oxford-AstraZeneca covid-19 vaccine as a precautionary move after reports of blood clots. But the EMA and the UK’s regulatory body say there is no indication that vaccination is linked to thromboembolic events https://t.co/sW8GRqcnLg
— The BMJ (@bmj_latest) March 11, 2021
Update to living systematic review on covid-19 in pregnancy
12 Mar, 2021 | 08:28h | UTCNews release: Update to living systematic review on covid-19 in pregnancy – The BMJ
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
12 Mar, 2021 | 08:23h | UTCSensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies – Nature
Perspective | Long Covid isn’t as unique as we thought
12 Mar, 2021 | 08:27h | UTCLong Covid isn’t as unique as we thought – Vox
Perspective | Immunity to SARS-CoV-2 variants of concern
12 Mar, 2021 | 08:24h | UTCImmunity to SARS-CoV-2 variants of concern – Science
Commentary on Twitter
Succinct and useful perspective on the many recent reports of the variable extent of immune evasion among major variants, today @ScienceMagazine https://t.co/xtRRYODjwk
by Daniel Altmann @BoytonRosemary @bealelab w/ @ScienceVisuals pic.twitter.com/2mubiYEe80— Eric Topol (@EricTopol) March 11, 2021
Managing Patients with Failing Kidney Allograft: Many Questions Remain
12 Mar, 2021 | 08:06h | UTC
CDC Interim Recommendations for Fully Vaccinated People: An Important First Step
12 Mar, 2021 | 08:22h | UTCCDC Interim Recommendations for Fully Vaccinated People: An Important First Step – JAMA
Original Guidance and Commentaries: New CDC Guideline for fully vaccinated individuals says people can get together indoors without masks. Precautions should continue in public.